The novel and transferable erm(51) gene confers macrolides, lincosamides and streptogramins B (MLSB ) resistance to clonal Rhodococcus equi in the environment

Environ Microbiol. 2020 Jul;22(7):2858-2869. doi: 10.1111/1462-2920.15020. Epub 2020 May 4.

Abstract

The use of mass antimicrobial treatment has been linked to the emergence of antimicrobial resistance in human and animal pathogens. Using whole-genome single-molecule real-time (SMRT) sequencing, we characterized genomic variability of multidrug-resistant Rhodococcus equi isolated from soil samples from 100 farms endemic for R. equi infections in Kentucky. We discovered the novel erm(51)-encoding resistance to MLSB in R. equi isolates from soil of horse-breeding farms. Erm(51) is inserted in a transposon (TnErm51) that is associated with a putative conjugative plasmid (pRErm51), a mobilizable plasmid (pMobErm51), or both enabling horizontal gene transfer to susceptible organisms and conferring high levels of resistance against MLSB in vitro. This new resistant genotype also carries a previously unidentified rpoB mutation conferring resistance to rifampicin. Isolates carrying both vapA and erm(51) were rarely found, indicating either a recent acquisition of erm(51) and/or impaired survival when isolates carry both genes. Isolates carrying erm(51) are closely related genetically and were likely selected by antimicrobial exposure in the environment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • DNA Transposable Elements / genetics
  • Drug Resistance, Bacterial / genetics*
  • Farms
  • Gene Transfer, Horizontal
  • Genome, Bacterial / genetics
  • Horses
  • Lincosamides / pharmacology
  • Macrolides / pharmacology
  • Microbial Sensitivity Tests
  • Plasmids / genetics
  • Rhodococcus equi / drug effects*
  • Rhodococcus equi / genetics*
  • Streptogramin B / pharmacology
  • Streptogramin Group B / pharmacology
  • Virginiamycin / pharmacology

Substances

  • Anti-Bacterial Agents
  • DNA Transposable Elements
  • Lincosamides
  • Macrolides
  • Streptogramin Group B
  • Virginiamycin
  • Streptogramin B
  • virginiamycin factor S1